Exhibiting at VIV Asia 2025

Reber Genetics Co., Ltd. is a leading Taiwanese biotechnology company specializing in the development, manufacturing, and export of innovative animal vaccines. Based in Taipei City, Taiwan, the company focuses on delivering effective biological solutions aimed at enhancing animal health, immunity, and productivity. With advanced research capabilities and a commitment to quality, Reber Genetics Co., Ltd. serves the global veterinary industry by providing top-tier vaccines tailored for swine and other livestock.

Core Business

Reber Genetics Co., Ltd. is primarily engaged in the research, development, production, and export of animal vaccines. The company's products are designed to address critical health challenges faced by livestock producers, particularly in the swine industry. With a strong emphasis on research-driven innovation, Reber Genetics Co., Ltd. is dedicated to improving animal health through safe and effective vaccines.

Product and Service Offerings

The company offers a comprehensive range of animal vaccines targeting various diseases prevalent in the livestock industry. Their product portfolio includes:

• Animal Vaccines:
  • PRRSFREE™:
    A vaccine designed to provide immunity against Porcine Reproductive and Respiratory Syndrome (PRRS), a highly contagious viral disease that significantly affects swine herds worldwide.
  • CIRCOFREE:
    A vaccine developed to combat Porcine Circovirus Type 2 (PCV2), a major cause of wasting and immunosuppression in pigs.
  • PCCOM:
    A specialized vaccine aimed at providing effective protection against diseases impacting pig herds.

Reber Genetics Co., Ltd. focuses on producing vaccines that enhance herd health, improve productivity, and minimize economic losses associated with disease outbreaks.

Specialization and Core USP

Reber Genetics Co., Ltd. distinguishes itself through the following unique selling propositions:

• Research-Driven Innovation:
  The company invests heavily in research and development to create effective vaccines that address key disease challenges in the swine industry.

• Tailored Solutions:
  Providing vaccines designed to meet the specific needs of livestock producers, ensuring high efficacy and safety.

• Global Reach:
  Active distribution and export operations, particularly in regions where livestock farming is a significant industry.

• High-Quality Standards:
  Strict adherence to manufacturing protocols and quality control measures to ensure consistent product performance.

Financial Strength

Reber Genetics Co., Ltd. has demonstrated stable financial growth through its continued success in the animal vaccine market. Although specific revenue figures are not publicly available, the company’s strong market presence and steady client base indicate a solid financial foundation.

Shipment Data

The company actively exports its vaccines to various countries, particularly focusing on markets with significant swine farming operations. Reber Genetics Co., Ltd.’s products are well-received due to their proven efficacy and compatibility with existing animal health management systems.

Target Market

The company’s primary target market includes:

• Swine farms and livestock producers
• Veterinary pharmaceutical distributors
• Agricultural cooperatives
• Research institutions focused on animal health

Capabilities

Reber Genetics Co., Ltd. offers comprehensive capabilities including:

• Product Development:
  Expertise in developing high-quality vaccines for swine and other livestock.

• Research and Innovation:
  Investing in continuous research to enhance product efficacy, safety, and ease of use.

• Technical Support:
  Providing guidance on vaccine application, dosage recommendations, and health management practices.

• Quality Control:
  Adopting stringent quality assurance protocols to ensure reliable and effective vaccine production.

Certifications and Compliance

Reber Genetics Co., Ltd. adheres to international standards for vaccine production and quality control. While specific certifications are not publicly disclosed, the company follows rigorous protocols to maintain product safety and efficacy.

Major Achievements

The company has successfully launched various vaccines that have gained acceptance in international markets. Its commitment to research-driven innovation and product quality has contributed to its growing reputation as a trusted provider of animal health solutions.

Customer Testimonials

No publicly available customer testimonials were found. However, the company’s consistent market presence and positive reception of its products indicate high levels of customer satisfaction.

Reber Genetics Co., Ltd. continues to enhance its global reach by developing advanced vaccines that contribute to improved animal health, productivity, and welfare across the livestock industry.